IBP

Indo-Bangla Pharmaceuticals Limited · Pharmaceuticals and Chemicals · Cat B

9/100

High risk

৳18.0

Score breakdown

Technical read

RSI (14)67.8

MACDbullish

Bollingerinside bands (+1.3σ)

Price cycle (Wyckoff)DIST

Health trenddeteriorating

Flow pressureaccumulation

Valuation

Fair value ()

Upside—

Dividend yield+0.10%

Fundamental verdictAT-RISK

Confidence—

Levels

Resistance

৳18.3

৳18.9

৳19.5

৳20.2

Support

৳17.9

৳17.3

৳16.7

৳16.1

Historical bounce zones

May 7, 2025: ৳9.1→৳11 +21%

Jun 22, 2025: ৳9→৳15.6 +73%

Oct 19, 2025: ৳10.6→৳12.3 +16%

Nov 13, 2025: ৳10→৳14.1 +41%

Nov 17, 2025: ৳10.7→৳12.4 +16%

Jan 28, 2026: ৳11.6→৳14.5 +25%

Mar 8, 2026: ৳11.9→৳14.2 +19%

May 7, 2026: ৳12.2→৳16.9 +39%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -5.4% / -1% / 4.9%

30-day 31% vs 42% market avg Typical move: -9.1% / -1.7% / 8.3%

Signals: RSI>70 overbought|Bearish Harami

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (dormant/dirty)

Reference stopn/a

Reference target—

Timing notestay out

Elevated (score 174) — acceptable only with real earnings and sponsor backing; artificial-activity lens applies. Phase: DORMANT (38% >200-MA, flow ACC). Elevated sharp-fall risk 12%. ⚠ Balance sheet DETERIORATING (Altman Z falling) — early warning. [fundamentals AT-RISK (dividend cut risk), yield 0.1%]

Market activity

Block activity

Block trade ৳0.6M (1 trade), 0.8× normal public volume, institutional ownership +10.1pp.